Wiregraph

Market coverage built from listed-company disclosures. Email [email protected] for any enquiries.

Copyright © 2025-2026 Wiregraph.com | Market data and charting by TradingView.com

BAVARIAN NORDIC

BAVA.CODK0015998017NASDAQ CopenhagenDKDKK
Stock price
BAVARIAN NORDIC
Loading chart...

Coverage

Latest articles

Nations stockpile mpox vaccine amid rising geopolitical fears
9 Jul 2025, 14:48BAVA.CONASDAQ Copenhagen

Filings

Recent filings

FilingDate
Bavarian Nordic receives USD 25 million milestone payment after submission of important IMVAMUNE® data to the U.S. Health Authorities19 Nov 2008
Bavarian Nordic reports successful safety data from Phase II study with IMVAMUNE®5 Nov 2008
Bavarian Nordic A/S - Interim Report for the period 1 January to 30 September 20084 Nov 2008
Bavarian Nordic awards warrants to management and certain employees and introduces incentive programme for all employees17 Oct 2008
Bavarian Nordic announces positive mature Phase II results from newly acquired prostate cancer vaccine7 Oct 2008
Bavarian Nordic A/S - Interim Report for the period 1 January to 30 June 200819 Aug 2008
Bavarian Nordic announces partnership with National Cancer Institute in the US and obtains rights to a new vaccine candidate
Search

Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.

Bavarian Nordic sells vaccine voucher for $160 million
20 Jun 2025, 17:26BAVA.CONASDAQ Copenhagen

Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.

  • Previous
  • 1
  • 2
  • 3
  • Next
13 Aug 2008
Bavarian Nordic files patent infringement suit against Oxford BioMedica30 Jun 2008
Bavarian Nordic reports interim data from Phase I/II studies with breast cancer vaccine19 Jun 2008
Bavarian Nordic enters clinical trials with prostate cancer vaccine3 Jun 2008
Bavarian Nordic enters clinical trials with HIV multiantigen vaccine27 May 2008
Bavarian Nordic A/S - Report on the Results of the Extraordinary General Meeting, held 26 May 200826 May 2008
  • Previous
  • 1
  • More pages
  • 58
  • 59
  • 60
  • More pages
  • 78
  • Next
Company
BAVARIAN NORDIC
BAVA.CONASDAQ Copenhagen
Website: Unavailable
Coverage
14
Filings
927